Adakveo

Indicated For

sickle cell disease

About This Medication

# Adakveo Patient Assistance Program Guide: Getting Crizanlizumab at Low Cost ## Overview Adakveo (crizanlizumab) is a prescription medication used to treat sickle cell disease. If you're struggling to afford this medication, the Novartis Patient Assistance Foundation (NPAF) offers a program to help eligible patients access Adakveo at reduced or no cost. ## Who Can Apply? You may qualify if you meet any of these criteria: - You are uninsured - You have insurance but cannot afford your copay, coinsurance, or deductible - Your annual household income falls within Novartis's income limits (limits vary based on family size and state) The program accepts applications from U.S. residents regardless of citizenship status. ## Income Limits Income eligibility varies by household size and geographic location. Generally, the program accommodates patients earning up to 400% of the federal poverty level, though this can vary. Contact Novartis directly at **(800) 282-7630** to learn your specific income threshold. ## Insurance Requirements You do not need to be uninsured to qualify. The program helps patients with: - Commercial insurance plans who cannot afford out-of-pocket costs - Medicare or Medicaid (with restrictions—call to confirm your specific coverage) - Any insurance gap or affordability issue If you have insurance, you will typically be asked to apply your insurance benefits first, and NPAF assistance covers remaining costs. ## What You'll Need to Apply Before starting your application, gather these documents: 1. **Proof of Income** - Recent tax return (last 2 years) - Current pay stubs - Proof of benefits (Social Security, disability, unemployment) - If self-employed: business tax returns or profit/loss statement 2. **Completed NPAF Application Form** - Available online at https://pap.novartis.com - Ask your doctor's office for a paper copy if needed 3. **Prescriber Form** - Your doctor must complete a form confirming: - Medical necessity for Adakveo - Your sickle cell disease diagnosis - Your current medical status 4. **Insurance Information** (if applicable) - Insurance card copy - Explanation of Benefits (EOB) showing medication costs ## 4-Step Application Process **Step 1: Gather Documents** Collect the four items listed above. This typically takes 1–2 weeks. **Step 2: Complete Application** Fill out the NPAF form online or by mail. The online process takes 10–15 minutes. Be accurate about your income and household size—this determines eligibility. **Step 3: Submit to Novartis** Submit your application along with supporting documents via: - **Online:** https://pap.novartis.com (fastest) - **Phone:** (800) 282-7630 (staff can help you apply) - **Mail:** Address provided on application form **Step 4: Wait for Approval** Novartis reviews your application and notifies you of approval status within 7–10 business days. Once approved, you'll receive instructions for accessing your medication at no or reduced cost. ## Timeline and Reauthorization Approval typically takes **7–10 business days** after submission. Your eligibility is valid for a specific period (varies by individual circumstances). You'll be notified when reauthorization is needed. Plan ahead: submit renewal applications at least 2–3 weeks before your current authorization expires. ## Additional Savings Options Even if you don't qualify for the assistance program, Novartis offers a **savings card** that may reduce your medication costs. Ask your pharmacist or doctor about this option. ## Questions? Contact Novartis **Phone:** (800) 282-7630 **Website:** https://pap.novartis.com **Hours:** Monday–Friday, 9 AM–5 PM ET Novartis patient advocates can answer questions about eligibility, help you apply, and address concerns about your application status. ## Next Steps 1. Call your doctor's office and ask about the Novartis Patient Assistance Program 2. Gather proof-of-income documents 3. Visit https://pap.novartis.com or call (800) 282-7630 to start your application 4. Submit all documents together—incomplete applications delay processing 5. Watch your mail or email for approval status You deserve access to the medication you need. Apply today.

Program information last verified: March 25, 2026